Skip to content

Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is persistent airflow limitation caused by damage to airways and lung tissue, most often from inhaled exposures.

Ventolin Evohaler

Salbutamol

100mcg

Ventolin Evohaler is salbutamol 100mcg as a pressurised inhalation solution for asthma and COPD, a fast-acting beta2 agonist.

From$20.40/ inhalerView

Symbicort

Budesonide, Formoterol

160/4.5mcg

Budesonide with formoterol 160/4.5mcg as an inhalation powder, used for asthma and COPD. A corticosteroid for the swelling, an agonist for the airway.

From$46.75/ inhalerView

Advair Diskus

Salmeterol, Fluticasone

100/50 · 250/50 · 500/50mcg

Salmeterol with fluticasone inhalation powder in three strengths, used in the management of asthma and COPD. A long-acting beta2-agonist with a corticosteroid.

From$106.55/ inhalerView

Pulmicort

Budesonide

100 · 200mcg

Budesonide 100mcg and 200mcg, as inhalation powder and nebuliser suspension, used for asthma and chronic obstructive pulmonary disease.

From$45.05/ inhalerView

Combivent

Ipratropium, Salbutamol

50/20mcg

Ipratropium with salbutamol 50/20mcg as a pressurised inhalation, used in the management of chronic obstructive pulmonary disease. Two bronchodilators.

From$22.10/ inhalerView

Seroflo Inhaler

Fluticasone, Salmeterol

25/125 · 25/250mcg

Seroflo Inhaler carries fluticasone with salmeterol as a pressurised suspension for asthma and COPD, a corticosteroid with a long-acting agonist.

From$34.00/ inhalerView

Spiriva

Tiotropium

9mcg

Tiotropium 9mcg as an inhalation powder in hard capsules, used in the management of chronic obstructive pulmonary disease. A long-acting M3 antagonist.

From$38.25/ inhalerView

Tiova Rotacap

Tiotropium

15caps

Tiova Rotacap is tiotropium in hard capsules loaded into a device, for chronic obstructive pulmonary disease. A long-acting M3 antagonist.

From$106.00/ bottleView

Ventolin Pills

Salbutamol

2 · 4mg

Ventolin Pills are salbutamol 2mg and 4mg tablets for asthma and COPD, the swallowed form of the beta2 agonist rather than the inhaled one.

From$0.47/ tabletView

Proair Inhaler

Salbutamol

100mcg

Proair Inhaler is salbutamol 100mcg as a pressurised suspension for asthma and COPD, a short-acting beta2 agonist for quick airway opening.

From$15.30/ inhalerView

Tiova Inhaler

Tiotropium

9mcg

Tiova Inhaler is tiotropium 9mcg as an inhalation powder for chronic obstructive pulmonary disease, blocking muscarinic receptors in the airway.

From$38.25/ inhalerView

Advair Rotahaler

Fluticasone, Salmeterol

50/250mg

Advair Rotahaler carries fluticasone with salmeterol as an inhalation powder for asthma and COPD, pairing an inhaled corticosteroid with a beta2-agonist.

From$1.81/ tabletView

Budecort

Budesonide

100mcg

Budecort is budesonide 100mcg as an inhalation powder for asthma and COPD. An inhaled corticosteroid with strong anti-inflammatory action in the airways.

From$35.02/ inhalerView

Theo-24 CR

Theophylline

400mg

Theo-24 CR is theophylline 400mg in a modified-release capsule for asthma and COPD, a methylxanthine that relaxes the bronchial muscle.

From$0.60/ tabletView

Uniphyl CR

Theophylline

400mg

Uniphyl CR is theophylline 400mg as a modified-release tablet rather than a capsule, for asthma and COPD. It inhibits the phosphodiesterase enzymes.

From$0.57/ tabletView

Theo-24 SR

Theophylline

200mg

Theo-24 SR is theophylline at the lower 200mg modified-release strength for asthma and COPD, a xanthine that raises cyclic AMP in the airway.

From$1.33/ tabletView

Proventil

Salbutamol

100mcg

Salbutamol 100mcg as a pressurised inhalation suspension, used for asthma and chronic obstructive pulmonary disease. A short-acting beta2-agonist.

From$23.09/ inhalerView

Daliresp

Roflumilast

500mg

Daliresp is roflumilast 500mg film-coated tablets for chronic obstructive pulmonary disease. A PDE4 inhibitor, so anti-inflammatory rather than bronchodilating.

From$1.04/ tabletView

Key points

  • Post-bronchodilator spirometry is needed to confirm persistent obstruction and reduce confusion with asthma or heart disease.
  • Long-acting bronchodilators improve symptoms; inhaled corticosteroid is added for selected exacerbation-prone patterns rather than everyone.
  • Smoking cessation, vaccination, activity and pulmonary rehabilitation can reduce decline or improve function beyond inhalers alone.

The listings below are not a complete COPD plan; symptoms, exacerbations, eosinophils, technique and comorbidities affect inhaler choice.

Assessing impact and risk

Clinicians review breathlessness, cough, daily activity and previous flare-ups, then check inhaler technique and oxygen saturation. CT is not required for routine diagnosis but may identify emphysema or another condition. Alpha-1 antitrypsin deficiency testing is considered according to age, history and guidance.

Building treatment

One or two long-acting bronchodilators form the basis for many symptomatic patients. Inhaled corticosteroid can reduce exacerbations in selected people but raises pneumonia risk. A written flare plan, pulmonary rehabilitation and nutrition support help maintain independence; oxygen is prescribed only when objective criteria are met.

When to seek urgent care

Seek emergency care for severe or rapidly worsening breathlessness, blue or grey lips, confusion, drowsiness, chest pain, coughing blood or inability to speak in full sentences.

Further reading